Then, exogenous secretory leukocyte protease inhibitor (SLPI) was added into the cell culture to investigate whether it could maintain its tumor suppressor effect on E6-expressing HNSCC cells. This evidence concerns the gene SLPI and head and neck squamous cell carcinoma.